# DUSP7

## Overview
DUSP7 is a gene that encodes the protein dual specificity phosphatase 7, which is a member of the dual-specificity phosphatase (DUSP) family. This protein is categorized as a phosphatase, specifically involved in the dephosphorylation of mitogen-activated protein kinases (MAPKs), such as ERK1/2. DUSP7 plays a critical role in regulating MAPK signaling pathways, which are essential for various cellular processes, including proliferation, differentiation, and survival (PérezSen2019DualSpecificity; Bermudez2010The). The protein functions primarily in the cytoplasm, where it acts as an ERK-directed phosphatase, contributing to the negative feedback regulation of MAPK signaling (PérezSen2019DualSpecificity). DUSP7's activity is modulated through complex regulatory mechanisms, including transcriptional and post-translational modifications, allowing it to maintain cellular homeostasis and respond to environmental changes (PérezSen2019DualSpecificity). The gene's dysregulation has been associated with various diseases, including certain types of leukemia and CLN3 disease, highlighting its clinical significance (Lebrun2011Analysis; Bermudez2010The).

## Function
DUSP7, also known as MKP-X, is a dual-specificity phosphatase that plays a significant role in regulating the mitogen-activated protein kinase (MAPK) signaling pathways, particularly by dephosphorylating ERK1/2 isoforms. This regulation is crucial for controlling cellular processes such as proliferation, differentiation, and survival (Bermudez2010The). DUSP7 is part of a group of cytoplasmic ERK-specific MAPK phosphatases, which also includes DUSP6 and DUSP9. These phosphatases are involved in anchoring inactive ERK in the cytosol and may facilitate the transport of dephosphorylated ERKs from the nucleus back to the cytosol (Bermudez2010The).

In healthy human cells, DUSP7 primarily acts in the cytoplasmic compartment, where it functions as an ERK-directed phosphatase. It is involved in negative feedback loops that regulate MAPK signaling, ensuring that the signaling is appropriately modulated in response to various stimuli (PérezSen2019DualSpecificity). The regulation of DUSP7, like other DUSPs, is complex and involves multiple mechanisms, including transcriptional, post-transcriptional, and post-translational modifications, as well as sensitivity to oxidative stress (PérezSen2019DualSpecificity). These regulatory mechanisms allow DUSP7 to fine-tune MAPK signaling, maintaining cellular homeostasis and responding to changes in the cellular environment.

## Clinical Significance
DUSP7 has been implicated in various diseases due to its role in regulating MAP kinase signaling pathways. Alterations in DUSP7 expression or function can lead to significant clinical consequences. Overexpression of DUSP7 has been observed in acute leukemia, particularly in acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL), suggesting a potential role in the pathogenesis of these cancers (Ruckert2019Protein; Bermudez2010The). The dysregulation of DUSP7 may contribute to the aberrant cell signaling associated with tumorigenesis.

In the context of cell division, DUSP7 is crucial for proper chromosome alignment and segregation. Knockdown of DUSP7 results in increased levels of phospho-ERK2, leading to defects in chromosome alignment and segregation during mitosis. This can result in misaligned chromosomes in metaphase and increased lagging chromosomes in anaphase, potentially contributing to aneuploidy and tumorigenesis (Guo2021DUSP7).

DUSP7 has also been linked to CLN3 disease, where increased expression was observed in Cln3-deficient mice, indicating a possible involvement in the disease's pathology (Lebrun2011Analysis). These findings underscore the importance of DUSP7 in maintaining cellular homeostasis and its potential impact on disease when dysregulated.

## Interactions
DUSP7 interacts with several proteins, playing a crucial role in cellular processes. It is known to interact with ERK2 (also known as MAPK1) during mitosis, where it regulates the levels of phospho-ERK2, essential for proper chromosome alignment. This interaction is facilitated by the Kinase Interaction Motif (KIM) domain of DUSP7, and mutations in this domain can disrupt the interaction (Guo2021DUSP7). DUSP7 also dephosphorylates ERK2, affecting its activity and influencing mitotic progression (Guo2021DUSP7).

In mouse oocytes, DUSP7 interacts with cPKC isoforms, dephosphorylating them to regulate nuclear envelope breakdown during meiotic resumption. This interaction is crucial for maintaining proper Cdk1/CycB activity levels, which are necessary for meiosis reinitiation and chromosome alignment (Tischer2016The). DUSP7's role in these processes is independent of its interaction with ERK1/2, as shown by its ability to rescue certain phenotypes without binding to ERK1/2 (Tischer2016The).

DUSP7 is also involved in modulating paclitaxel resistance in breast cancer cells through its interaction with Let-7a-5p, a regulatory microRNA, and lncRNA SNHG16, which affects its expression (Zhao2023LncRNA).


## References


[1. (Guo2021DUSP7) Xiao Guo, Ivan Ramirez, Yenni A. Garcia, Erick F. Velasquez, Ankur A. Gholkar, Whitaker Cohn, Julian P. Whitelegge, Bobby Tofig, Robert Damoiseaux, and Jorge Z. Torres. Dusp7 regulates the activity of erk2 to promote proper chromosome alignment during cell division. Journal of Biological Chemistry, 296:100676, January 2021. URL: http://dx.doi.org/10.1016/j.jbc.2021.100676, doi:10.1016/j.jbc.2021.100676. This article has 7 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jbc.2021.100676)

2. (Zhao2023LncRNA) LncRNA SNHG16 modulates paclitaxel resistance in breast cancer by regulating Let-7a-5p/DUSP7. This article has 0 citations.

[3. (Ruckert2019Protein) Mariana Tannús Ruckert, Pamela Viani de Andrade, Verena Silva Santos, and Vanessa Silva Silveira. Protein tyrosine phosphatases: promising targets in pancreatic ductal adenocarcinoma. Cellular and Molecular Life Sciences, 76(13):2571–2592, April 2019. URL: http://dx.doi.org/10.1007/s00018-019-03095-4, doi:10.1007/s00018-019-03095-4. This article has 17 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1007/s00018-019-03095-4)

[4. (Bermudez2010The) O. Bermudez, G. Pagès, and C. Gimond. The dual-specificity map kinase phosphatases: critical roles in development and cancer. American Journal of Physiology-Cell Physiology, 299(2):C189–C202, August 2010. URL: http://dx.doi.org/10.1152/ajpcell.00347.2009, doi:10.1152/ajpcell.00347.2009. This article has 173 citations.](https://doi.org/10.1152/ajpcell.00347.2009)

[5. (PérezSen2019DualSpecificity) Raquel Pérez-Sen, María José Queipo, Juan Carlos Gil-Redondo, Felipe Ortega, Rosa Gómez-Villafuertes, María Teresa Miras-Portugal, and Esmerilda G. Delicado. Dual-specificity phosphatase regulation in neurons and glial cells. International Journal of Molecular Sciences, 20(8):1999, April 2019. URL: http://dx.doi.org/10.3390/ijms20081999, doi:10.3390/ijms20081999. This article has 42 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms20081999)

[6. (Lebrun2011Analysis) Anne-Hélène Lebrun, Parisa Moll-Khosrawi, Sandra Pohl, Georgia Makrypidi, Stephan Storch, Dirk Kilian, Thomas Streichert, Benjamin Otto, Sara E. Mole, Kurt Ullrich, Susan Cotman, Alfried Kohlschütter, Thomas Braulke, and Angela Schulz. Analysis of potential biomarkers and modifier genes affecting the clinical course of cln3 disease. Molecular Medicine, 17(11–12):1253–1261, August 2011. URL: http://dx.doi.org/10.2119/molmed.2010.00241, doi:10.2119/molmed.2010.00241. This article has 46 citations and is from a peer-reviewed journal.](https://doi.org/10.2119/molmed.2010.00241)

[7. (Tischer2016The) Thomas Tischer and Melina Schuh. The phosphatase dusp7 drives meiotic resumption and chromosome alignment in mouse oocytes. Cell Reports, 17(5):1426–1437, October 2016. URL: http://dx.doi.org/10.1016/j.celrep.2016.10.007, doi:10.1016/j.celrep.2016.10.007. This article has 18 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1016/j.celrep.2016.10.007)